Spinal and bulbar muscular atrophy (SBMA) is a polyglutamine disease caused by the expansion of a CAG repeat in the androgen receptor (AR) gene. We generated a transgenic mouse model carrying a full-length AR containing 97 CAGs. Three of the five lines showed progressive muscular atrophy and weakness as well as diffuse nuclear staining and nuclear inclusions consisting of the mutant AR. These phenotypes were markedly pronounced in male transgenic mice, and dramatically rescued by castration. Female transgenic mice showed only a few manifestations that markedly deteriorated with testosterone administration. Nuclear translocation of the mutant AR by testosterone contributed to the phenotypic difference with gender and the effects of hormonal interventions. These results suggest the therapeutic potential of hormonal intervention for SBMA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0896-6273(02)00834-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Sarcopenia has been linked to brain atrophy and there is lack of information on specific muscle groups that may contribute to this link. The psoas muscles are sensitive to sarcopenia and thus may sensitively relate to brain aging and Alzheimer disease risk.
Method: This study utilized 7,149 healthy individuals across four sites (Mean age 53.
Public Health.
Alzheimers Dement
December 2024
Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Background: Sarcopenia is a prevalent condition defined by a loss of muscle mass associated with reduction in muscle power and physical performance. It is associated with several adverse outcomes such as risk of falls and fractures, hospitalization and higher mortality. It can be triggered by several clinical conditions and dementia is one of them.
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
Medical College, the Catholic University of Korea, Seoul, Korea, Republic of (South).
Background: Although previous studies have demonstrated cognitive impairment in elderly individuals with sarcopenia and its neuronal substrates, there is no comprehensive model integrating multiple brain pathologies to predict cognitive impairment associated with sarcopenia. The aim of this study was to explore a comprehensive prediction model for cognitive impairment in sarcopenia using multimodal neuroimaging methods in non-demented older adults.
Method: This cross-sectional study used data from the Catholic Aging Brain Imaging Database study, a population-based cohort study with magnetic resonance imaging (MRI) scans, positron emission tomography (PET) scans, and clinical data.
Biomarkers.
Alzheimers Dement
December 2024
National Institute of Neurological Disorders and Stroke, Rockville, MD, USA.
Background: Access to biospecimens is an oft cited challenge to the progress in research on neurological disorders. Access to clinical biospecimens for development of validated biomarkers and improved cellular models of Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) are cited as priorities across several NIH AD/ADRD Research Implementation Milestones (https://www.nia.
View Article and Find Full Text PDFDeveloping Topics.
Alzheimers Dement
December 2024
Pontifical Catholic University, Londrina, Parana, Brazil.
Background: The association of Alzheimer's disease (AD) and sarcopenia diagnoses is quite common, but frequently sarcopenia is underdiagnosed in this population and it may be contributing to the worsening of functionality in the person with AD.
Method: Fifty-five adults over age 60 from a public outpatient clinic in Londrina - Parana- Brazil diagnosed with Alzheimer's disease were followed during the years 2022 and 2023. They were subjected to a sociodemographic questionnaire, BMI assessment, cognitive assessment using the MMSE, functionality assessment using the Katz Index and to a sarcopenia screening test SARC-F +CC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!